Buy Retatrutide 50mg: Triple Agonist Peptide for Metabolic & Obesity Research

Retatrutide (50mg) is a next-generation triple hormone receptor agonist that simultaneously targets GLP-1, GIP, and glucagon receptors. This mid-to-high capacity 50mg vial is ideal for researchers conducting dose-response, medium-to-long-term, or bulk reconstitution studies. Retatrutide is one of the most potent peptides studied for substantial weight loss, appetite suppression, energy expenditure, glucose control, and fat metabolism in obesity and type 2 diabetes experimental models.

Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈ Molecular Weight: 4813.5 g/mol (approximate) Purity: ≥99% (lyophilized, research-grade)

Important Notice: This peptide is strictly intended for research and laboratory use only. Not for human consumption, diagnostic, therapeutic, or veterinary purposes. Please review and agree to our Terms and Conditions before ordering.

What is Retatrutide?

Retatrutide is a synthetic multi-agonist peptide designed to activate three key metabolic pathways at once:

• GLP-1 receptor — for appetite suppression and glucose-dependent insulin secretion
• GIP receptor — for enhanced insulin sensitivity and lipid metabolism
• Glucagon receptor — for increased energy expenditure and lipolysis

This triple mechanism delivers more comprehensive metabolic effects than dual agonists like tirzepatide, making Retatrutide a leading tool in current incretin, obesity, and metabolic research.

Mechanism of Action in Research

In experimental models, Retatrutide:

• Strongly suppresses appetite and reduces caloric intake
• Boosts energy expenditure through glucagon receptor activation
• Promotes significant body weight and visceral fat reduction
• Improves insulin sensitivity and glycemic control
• Enhances lipid profiles and cardiometabolic markers

Research suggests Retatrutide may achieve superior weight loss compared to existing dual GLP-1/GIP agonists.

Key Research Areas

The 50mg vial is particularly suited for:

• Medium-to-high dose and chronic administration studies
• Long-term obesity and type 2 diabetes models
• Bulk reconstitution and stability testing
• Comparative triple vs. dual agonist research
• Energy balance, thermogenesis, and body composition analysis

Research Applications

The 50mg vial supports:

• Dose-escalation and extended metabolic experiments
• Animal models of obesity and metabolic syndrome
• Body composition and fat mass quantification
• Pharmacokinetic and long-term efficacy studies
• Multi-receptor agonist comparative investigations

Why Choose 99% Pure Retatrutide 50mg?

Our Retatrutide 50mg provides purity for reliable, reproducible results in receptor activation, appetite regulation, and metabolic endpoint studies. Third-party tested and lyophilized for optimal stability in advanced research settings.

In summary, Retatrutide 50mg is a high-capacity triple agonist peptide for advanced research into weight loss, obesity, glucose control, energy expenditure, and metabolic health. Scale your incretin and multi-agonist studies with this premium research tool.